CTI Clinical Trial & Consulting Services (CTI), Mahzi Therapeutics Inc. (Mahzi), and the Pitt Hopkins Research Foundation (PHRF) are proud to announce a collaboration aimed at accelerating the development of a therapy for Pitt Hopkins Syndrome, a rare genetic neurodevelopmental disorder.